Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynamin 1 pseudogene 48 (DNM1P48) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a functional gene (dynamin 1, DNM1) but is generally non-functional, typically not transcribed or translated into a protein[1]. The canonical functional gene, dynamin 1, encodes a large GTPase critical for clathrin-mediated endocytosis and vesicular trafficking in neurons, and is involved in several neurological and cancer processes[1][2]. However, there are over sixty conserved copies of DNM1-like pseudogene sequences elsewhere in the human genome, especially on chromosomes Y and 15, and these copies (such as DNM1P48) are not known to encode functional proteins or have recognized roles in physiology or pathology[1]. Thus, DNM1P48 itself is not a receptor, enzyme, transporter, or drug target, nor is it implicated in disease or therapeutics. If you are seeking information on the functional protein dynamin 1 or its therapeutic relevance, refer instead to the actual DNM1 gene and its associated protein, dynamin 1[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynamin 1 pseudogene 48 (DNM1P48).